A Study of AQUAVAN® Injection in the Presence of Pre-Medication in Patients Undergoing Elective Colonoscopy
Bio Analytical Research Corporation
This study was designed to assess the safety and efficacy of AQUAVAN® Injection in providing
adequate sedation in patients undergoing colonoscopy. Prior to the procedure, patients
received fentanyl citrate for pain management followed five minutes later by AQUAVAN®
Injection for sedation. Throughout the procedure, study personnel assessed the patient's
vital signs and depth of sedation. After the procedure, the patient, physician, and an
evaluator were asked to complete satisfaction surveys.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.